{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:45:09Z","timestamp":1782272709759,"version":"3.54.5"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.semarthrit.2015.05.010","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T10:47:19Z","timestamp":1432205239000},"page":"361-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Anti-TNF-\u03b1 therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients"],"prefix":"10.1016","volume":"45","author":[{"given":"Leyre","family":"Riancho-Zarrabeitia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Calvo-R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Mesquida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo M.","family":"Adan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Herreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Peiteado-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Cordero-Coma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Garc\u00eda Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Ortego-Centeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ma\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"S\u00e1nchez-Burs\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen\u00e9n","family":"Gonz\u00e1lez-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Fonollosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Santos-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gonz\u00e1lez-Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Loricera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinitario","family":"Pina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2015.05.010_bib1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.mcna.2011.08.004","article-title":"Sarcoidosis","volume":"95","author":"Hamzeh","year":"2011","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.iac.2012.08.005","article-title":"Sarcoidosis","volume":"32","author":"Culver","year":"2012","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/ICU.0b013e32833eae4d","article-title":"Neuro-ophthalmic sarcoidosis","volume":"21","author":"Phillips","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08820530500231938","article-title":"Sarcoidosis","volume":"20","author":"Bonfioli","year":"2005","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/ICU.0b013e328358c7a6","article-title":"Different ophthalmologic manifestations of sarcoidosis","volume":"23","author":"Umur","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib7","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib8","first-page":"275","article-title":"Anti-TNF-alpha therapy in the management of severe neurosarcoidosis: a report of five cases from a single centre and literature review","volume":"32","author":"Riancho-Zarrabeitia","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.disamonth.2009.04.008","article-title":"Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics","volume":"55","author":"Lazarus","year":"2009","journal-title":"Dis Mon"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.disamonth.2009.05.002","article-title":"Sarcoidosis: extrathoracic manifestations","volume":"55","author":"Holmes","year":"2009","journal-title":"Dis Mon"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ccm.2008.03.012","article-title":"Treatment of sarcoidosis","volume":"29","author":"Baughman","year":"2008","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1445-5994.2011.02457.x","article-title":"Medically refractory neurosarcoidosis treated with infliximab","volume":"41","author":"Pereira","year":"2011","journal-title":"Intern Med J"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib13","doi-asserted-by":"crossref","DOI":"10.3410\/M2-13","article-title":"Update on bioagent therapy in sarcoidosis","volume":"2","author":"Cottin","year":"2010","journal-title":"F1000 Med Rep"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib14","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib15","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.127.3.1064","article-title":"Treatment of sarcoidosis with infliximab","volume":"127","author":"Doty","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.rmed.2008.08.016","article-title":"Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis","volume":"103","author":"Sodhi","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/09273940902818861","article-title":"International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS)","volume":"17","author":"Herbort","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273940801899822","article-title":"International Uveitis Study Group IUSG: clinical classification of uveitis","volume":"16","author":"Deschenes","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","article-title":"Standardization of vitreal inflammatory activity in intermediate and posterior uveitis","volume":"92","author":"Nussenblatt","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ophtha.2004.12.034","article-title":"Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series","volume":"112","author":"Nussenblatt","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib22","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ccm.2008.03.008","article-title":"Hepatic, ocular, and cutaneous sarcoidosis","volume":"29","author":"Rose","year":"2008","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9394(86)90001-2","article-title":"Ocular involvement in chronic sarcoidosis","volume":"102","author":"Jabs","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11882-013-0409-1","article-title":"Noninfectious immune-mediated uveitis and ocular inflammation","volume":"14","author":"Pan","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1 Suppl 70","key":"10.1016\/j.semarthrit.2015.05.010_bib26","first-page":"S94","article-title":"Refractory polymyalgia rheumatica as presenting manifestation of large-vessel vasculitis associated to sarcoidosis. Successful response to adalimumab","volume":"30","author":"Bejerano","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10067-005-0037-9","article-title":"Treatment of therapy-resistant sarcoidosis with adalimumab","volume":"25","author":"Callejas-Rubio","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib28","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1164\/ajrccm.184.10.1214","article-title":"Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis","volume":"184","author":"Kamphuis","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib29","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.rmed.2006.02.017","article-title":"Effectiveness of infliximab in treating selected patients with sarcoidosis","volume":"100","author":"Saleh","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.eye.6701689","article-title":"Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab)","volume":"19","author":"Benitez-Del-Castillo","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bjo.2003.037192","article-title":"Anti-TNF-alpha therapy for sight threatening uveitis","volume":"89","author":"Lindstedt","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archopht.123.7.903","article-title":"A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes","volume":"123","author":"Suhler","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archophthalmol.2009.141","article-title":"Infliximab therapy for refractory uveitis: 2-year results of a prospective trial","volume":"127","author":"Suhler","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5414\/CPP43007","article-title":"Infliximab in chronic ocular inflammation","volume":"43","author":"Baughman","year":"2005","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib35","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00296-007-0359-9","article-title":"Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab","volume":"27","author":"Cruz","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bjophthalmol-2012-302292","article-title":"Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial","volume":"97","author":"Suhler","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib37","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.ophtha.2012.02.018","article-title":"Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients","volume":"119","author":"Diaz-Llopis","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib38","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00417-011-1844-0","article-title":"Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis","volume":"250","author":"Erckens","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib39","doi-asserted-by":"crossref","first-page":"286857","DOI":"10.1155\/2013\/286857","article-title":"Off-label uses of anti-TNF therapy in three frequent disorders: Behcet\u05f3s disease, sarcoidosis, and noninfectious uveitis","volume":"2013","author":"Sanchez-Cano","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/MAJ.0b013e3180318fbc","article-title":"Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation","volume":"27","author":"Theodossiadis","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00915816","article-title":"Ocular inflammatory effects of intravitreally injected tumor necrosis factor-alpha and endotoxin","volume":"14","author":"Fleisher","year":"1990","journal-title":"Inflammation"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib42","first-page":"47","article-title":"Ocular inflammatory effects of intravitreally-injected tumor necrosis factor","volume":"133","author":"Rosenbaum","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib43","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0012-3692(15)50471-6","article-title":"Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial","volume":"128","author":"Baughman","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.20904","article-title":"A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis","volume":"53","author":"Smith","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib45","first-page":"67","article-title":"Update on the use of systemic biologic agents in the treatment of noninfectious uveitis","volume":"8","author":"Pasadhika","year":"2014","journal-title":"Biologics"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib46","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/09273948.2013.844265","article-title":"Long-term treatment with golimumab for severe uveitis","volume":"22","author":"Miserocchi","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.reuma.2014.10.006","article-title":"Effectiveness of certolizumab pegol in chronic anterior uveitis associated to Crohn\u05f3s disease and ankylosing spondylitis","volume":"11","author":"Maiz Alonso","year":"2015","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09273948.2014.967779","article-title":"Certolizumab Pegol a New Anti-TNF-\u03b1 in the Armamentarium against Ocular Inflammation","volume":"17","author":"Lloren\u00e7","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib49","first-page":"702","article-title":"New options for uveitis treatment","volume":"6","author":"He","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib50","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/archopht.125.7.895","article-title":"Infliximab therapy for the treatment of refractory ocular inflammatory disease","volume":"125","author":"Sobrin","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib51","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/eye.2009.203","article-title":"Switching biologic agents for uveitis","volume":"23","author":"Dhingra","year":"2009","journal-title":"Eye"},{"issue":"4 Suppl 67","key":"10.1016\/j.semarthrit.2015.05.010_bib52","first-page":"S54","article-title":"Efficacy of adalimumab in patients with Behcet\u05f3s disease unsuccessfully treated with infliximab","volume":"29","author":"Olivieri","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib53","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib54","first-page":"76","article-title":"Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them","volume":"25","author":"Baughman","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib55","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10792-010-9372-1","article-title":"Effects of infliximab in the treatment of refractory posterior uveitis of Behcet\u05f3s disease after withdrawal of infusions","volume":"30","author":"Adan","year":"2010","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib56","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib57","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis? A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib58","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.semarthrit.2011.05.005","article-title":"New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases","volume":"41","author":"Wendling","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib59","first-page":"645","article-title":"Sarcoid-related uveitis occurring during etanercept therapy","volume":"21","author":"Hashkes","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1445-5994.2011.02612.x","article-title":"New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication","volume":"42","author":"Tong","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib61","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.22238","article-title":"Development of sarcoidosis during etanercept therapy","volume":"55","author":"Gonzalez-Lopez","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.05.010_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-200552","article-title":"Sarcoid panuveitis associated with etanercept treatment, resolving with adalimumab","volume":"2013","author":"Dragnev","year":"2013","journal-title":"BMJ Case Rep"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721500116X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721500116X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T08:50:28Z","timestamp":1620809428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901721500116X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S004901721500116X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.05.010","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-TNF-\u03b1 therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}